首页 › 基金 › Tetragon Partners GP Ltd › CUE

Tetragon Partners GP Ltd 对 CUE 的持仓历史

CUE BIOPHARMA · 医疗保健

Tetragon Partners GP Ltd 在 Q2 2026 的 13F 申报中披露持有 CUE(CUE BIOPHARMA)93,819 股,市值约 US$3.0M,约占其申报组合的 0.48%,在其申报持仓中市值排名第 28 位。 Tetragon Partners GP Ltd 于 Q2 2026 首次申报该持仓。

最新持仓 (Q2 2026)93.82K 股
申报持仓市值$2.96M
组合权重0.48%
首次申报Q2 2026
最近变动新进
更新于2026-10-24

最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR

Tetragon Partners GP Ltd 对 CUE 的持仓演变

Tetragon Partners GP Ltd 于 Q2 2026 首次披露 CUE 持仓:93,819 股(约 US$3.0M)。

逐季持仓明细

季度股数金额变化
Q2 2026 93.82K $2.96M 新进

关于 CUE 与 13F 数据

CUE(CUE BIOPHARMA)属于医疗保健行业。我们追踪的基金中还有 28 只申报持有 CUE,申报仓位最大的包括:Bleichroeder LP (US$11.7M), Lion Point Capital, LP (US$1.7M), Squadron Capital Management LLC (US$1.6M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 CUE 的基金

查看 CUE 的全部基金持有人 →

常见问题

How long has Tetragon Partners GP Ltd held CUE?

Tetragon Partners GP Ltd has disclosed CUE holdings in 1 of the last 1 reported quarters, going back to Q2 2026.

What is Tetragon Partners GP Ltd's current position in CUE?

As of Q2 2026, Tetragon Partners GP Ltd holds 93.82K shares of CUE (CUE BIOPHARMA), valued at $2.96M, representing 0.48% of its reported portfolio and ranking #28.

Has Tetragon Partners GP Ltd been buying or selling CUE?

In the latest 13F filing (Q2 2026), Tetragon Partners GP Ltd newly opened its position in CUE.

Which other funds hold CUE?

Other major institutional holders of CUE include Bleichroeder LP, Lion Point Capital, LP, Squadron Capital Management LLC, among 28 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.